If a pre-seed company can raise $150,000 from angel investors in 10 minutes, it’s obvious the company has done something right.
In the case of Maritime BioLoggers, what they did right was pivot to help hospitals and pharmaceutical companies improve the transportation of blood samples.
The Halifax company got started a few years ago to help chart the movement of marine species, but last year it began asking healthcare providers whether they could use the BioLoggers technology. The response was overwhelming, and it is about to launch pilot projects with nine European hospitals.
“They were insanely willing to talk to us, which was really surprising,” said Co-Founder Franziska Broell in an interview. “We had long conversations and started to understand there was a huge value in what we were doing.”
A native of Germany, Broell came to Halifax for her PhD in biology at Dalhousie University, where she linked up with Andre Bezanson, a PhD candidate in biomedical engineering. Together, they devised a sensor product that could be tagged to marine animals to track their movements.
After their product was featured in Canadian Geographic and on CBC, oceans researchers began to contact them to buy the product. Broell and Bezanson formed a small business while they continued with their other (mainly academic) pursuits. Their only sales process was to set up a website and wait for people to contact them. They had sales of $150,000 over two years and also got requests from a hospital and pharma company for the product.